The final per-well assay
volume was 210 [micro]L, composed of 35 [micro]L [3H] PbTx-3, 35 [micro]L standard or sample, and 140 [micro]L rat brain membrane preparation (1 mg protein/ml).
com/reports/c46516) has announced the addition of "Development of Cell-Based Assays
(Technical Insights)" to their offering.
The active fraction was determined not to contain ATP by difference in chromatographic retention and by lack of ATP activity using an ATP-dependent in vitro luciferase assay
, described below under "ATP Assay
These new findings published in Toxicology in Vitro, the official journal of the European Society of Toxicology in Vitro, confirm the qNPA approach is beneficial in setting up toxicogenomics-based assay
systems to further evaluate these gene markers.
Transcriptional activation assay
in stably transfected MCF-7 cells.
This professional development guide thoroughly evaluates the capabilities, strengths, weaknesses, and expectations of leading assays
technologies to provide you with the information necessary to select and develop the appropriate assay
for the task at hand.
Sentigen Biosciences has initially targeted its Tango(TM) Assay
System to address the functionalization of G protein-coupled receptors (GPCRs) for pharmaceutical drug discovery and development.
The RapidQuant IgG assay
provides rapid, reproducible and accurate results in the most appropriate range for screening hybridoma culture media.
The purchase of the TaqMan(R) SNP Genotyping Assay
includes an immunity from suit under patents specified in the product insert to use only the amount purchased for the purchaser's own internal research when used with the separate purchase of an Authorized 5' Nuclease Core Kit.
Pyare Khanna, CEO of DiscoveRx said, "The PathHunter Beta-Arrestin assay
is another revolutionary offering from DiscoveRx which further confirms our commitment to provide novel, chemiluminescent assays
for both biochemical and cell based drug discovery research and screening.
38 surface samples were collected from these four anomalies and have been assayed
showing a similar level of gold value to those in the Stage 1 and 2 drilling assays
We believe Division Arrested Assay
Ready Cells(TM) have the potential to broadly impact cell-based drug discovery by turning cells into validated reagents and the company plans to aggressively promote their use.
DiscoveRx will focus on creating custom labeling and assay
development solutions for drug development customers, offering companies a strategic outsourcing option for kinase and protease assays
that will dramatically increase the pace of drug discovery.
Our partnership with Bio-Rad in the past has enabled CST to combine our antibody expertise with Bio-Rad's strength in multiplexed assay
technologies," said Christopher Bunker, CST's Director of Business Development.
The Company's new cell based assay
platform is called PathHunter(TM).